Which approach of total hip arthroplasty is the best efficacy and least complication?

Author:

Nitiwarangkul Lertkong,Hongku Natthapong,Pattanaprateep Oraluck,Rattanasiri Sasivimol,Woratanarat Patarawan,Thakkinstian Ammarin

Abstract

BACKGROUND Total hip arthroplasty is as an effective intervention to relieve pain and improve hip function. Approaches of the hip have been exhaustively explored about pros and cons. The efficacy and the complications of hip approaches remains inconclusive. This study conducted an umbrella review to systematically appraise previous meta-analysis (MAs) including conventional posterior approach (PA), and minimally invasive surgeries as the lateral approach (LA), direct anterior approach (DAA), 2-incisions method, mini-lateral approach and the newest technique direct superior approach (DSA) or supercapsular percutaneously-assisted total hip (SuperPath). AIM To compare the efficacy and complications of hip approaches that have been published in all MAs and randomized controlled trials (RCTs). METHODS MAs were identified from MEDLINE and Scopus from inception until 2023. RCTs were then updated from the latest MA to September 2023. This study included studies which compared hip approaches and reported at least one outcome such as Harris Hip Score (HHS), dislocation, intra-operative fracture, wound complication, nerve injury, operative time, operative blood loss, length of hospital stay, incision length and VAS pain. Data were independently selected, extracted and assessed by two reviewers. Network MA and cluster rank and surface under the cumulative ranking curve (SUCRA) were estimated for treatment efficacy and safety. RESULTS Finally, twenty-eight MAs (40 RCTs), and 13 RCTs were retrieved. In total 47 RCTs were included for reanalysis. The results of corrected covered area showed high degree (13.80%). Among 47 RCTs, most of the studies were low risk of bias in part of random process and outcome reporting, while other domains were medium to high risk of bias. DAA significantly provided higher HHS at three months than PA [pooled unstandardized mean difference (USMD): 3.49, 95% confidence interval (CI): 0.98, 6.00 with SUCRA: 85.9], followed by DSA/SuperPath (USMD: 1.57, 95%CI: -1.55, 4.69 with SUCRA: 57.6). All approaches had indifferent dislocation and intraoperative fracture rates. SUCRA comparing early functional outcome and composite complications (dislocation, intra-operative fracture, wound complication, and nerve injury) found DAA was the best approach followed by DSA/SuperPath. CONCLUSION DSA/SuperPath had better earlier functional outcome than PA, but still could not overcome the result of DAA. This technique might be the other preferred option with acceptable complications.

Publisher

Baishideng Publishing Group Inc.

Subject

Orthopedics and Sports Medicine

Reference106 articles.

1. The effect of elective total hip replacement on health-related quality of life.

2. Ammarullah MI, Hidayat T, Lamura MD, Jamari J. Relationship between deformation and running-in wear on hard-on-hard bearings from metal, ceramic, and diamond materials for total hip prosthesis. J Tribology 2023; 38: 69

3. Ammarullah MI, Santoso G, Gatot Santoso, Sugiharto S, Supriyono T, Kurdi O, Tauviqirrahman M, Winarni TI, Jamari J. Tresca stress study of CoCrMo-on-CoCrMo bearings based on body mass index using 2D computational model. J Tribology 2022; 33: 31-38

4. Hidayat T, Ismail R, Tauviqirrahman M, Saputra E, Ammarullah MI, Lamura MD, Bayuseno A, Jamari J. Investigation of mesh model for a finite element simulation of the dual-mobility prosthetic hip joint. J Tribology 2023; 38: 118-1401

5. The Current Concepts of Total Hip Arthroplasty

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3